Parallel Advisors LLC Has $700,000 Position in Amdocs Limited (DOX)

Parallel Advisors LLC boosted its holdings in Amdocs Limited (NASDAQ:DOX) by 9.8% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 10,582 shares of the technology company’s stock after acquiring an additional 945 shares during the quarter. Parallel Advisors LLC’s holdings in Amdocs were worth $700,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in DOX. Meeder Asset Management Inc. acquired a new stake in Amdocs in the second quarter worth $107,000. Bristol John W & Co. Inc. NY acquired a new stake in Amdocs in the first quarter worth $193,000. BNP Paribas Arbitrage SA raised its holdings in Amdocs by 102.4% in the second quarter. BNP Paribas Arbitrage SA now owns 4,373 shares of the technology company’s stock worth $289,000 after purchasing an additional 2,212 shares during the period. Element Capital Management LLC acquired a new stake in Amdocs in the first quarter worth $302,000. Finally, Hartford Investment Management Co. acquired a new stake in Amdocs in the second quarter worth $343,000. Institutional investors and hedge funds own 92.04% of the company’s stock.

Shares of DOX stock traded down $0.42 during trading hours on Monday, hitting $67.52. 351,722 shares of the company were exchanged, compared to its average volume of 643,279. Amdocs Limited has a 52 week low of $61.00 and a 52 week high of $71.72. The company has a market capitalization of $9.74 billion, a price-to-earnings ratio of 19.02, a P/E/G ratio of 2.11 and a beta of 0.57.



Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Thursday, May 10th. The technology company reported $0.95 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.95. Amdocs had a net margin of 11.36% and a return on equity of 15.07%. The company had revenue of $992.34 million during the quarter, compared to the consensus estimate of $980.59 million. During the same quarter in the prior year, the firm earned $0.94 earnings per share. The firm’s revenue was up 2.7% compared to the same quarter last year. sell-side analysts predict that Amdocs Limited will post 3.79 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 20th. Stockholders of record on Friday, June 29th were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 1.48%. The ex-dividend date was Thursday, June 28th. Amdocs’s dividend payout ratio is 28.17%.

Several research firms have weighed in on DOX. BidaskClub lowered shares of Amdocs from a “hold” rating to a “sell” rating in a report on Friday. Zacks Investment Research lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Wednesday, July 11th. ValuEngine lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Wednesday, May 2nd. Finally, JPMorgan Chase & Co. reiterated a “hold” rating on shares of Amdocs in a report on Monday, April 30th. One analyst has rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. Amdocs presently has an average rating of “Hold” and a consensus target price of $70.03.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide. The company offers customer experience and monetization solutions that allow its customers to contextual and personalize interactions.

Further Reading: Book Value Of Equity Per Share – BVPS Explained

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply